157 related articles for article (PubMed ID: 27702652)
21. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment.
Sormendi S; Wielockx B
Front Immunol; 2018; 9():40. PubMed ID: 29434587
[TBL] [Abstract][Full Text] [Related]
22. Prolyl hydroxylases and therapeutics.
Smith TG; Talbot NP
Antioxid Redox Signal; 2010 Apr; 12(4):431-3. PubMed ID: 19761407
[TBL] [Abstract][Full Text] [Related]
23. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
[TBL] [Abstract][Full Text] [Related]
24. β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions.
Eslavath RK; Sharma D; Bin Omar NAM; Chikati R; Teli MK; Rajanikant GK; Singh SS
Eur J Pharmacol; 2016 Nov; 791():405-411. PubMed ID: 27393459
[TBL] [Abstract][Full Text] [Related]
25. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression.
Yang G; Shi R; Zhang Q
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142830
[TBL] [Abstract][Full Text] [Related]
27. Oxygen sensing: a common crossroad in cancer and neurodegeneration.
Quaegebeur A; Carmeliet P
Curr Top Microbiol Immunol; 2010; 345():71-103. PubMed ID: 20582529
[TBL] [Abstract][Full Text] [Related]
28. Prolyl hydroxylases as regulators of cell metabolism.
Boulahbel H; Durán RV; Gottlieb E
Biochem Soc Trans; 2009 Feb; 37(Pt 1):291-4. PubMed ID: 19143649
[TBL] [Abstract][Full Text] [Related]
29. Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3.
Na YR; Woo DJ; Kim SY; Yang EG
Biochem Biophys Res Commun; 2016 Apr; 472(2):313-8. PubMed ID: 26940742
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal.
Dallatu MK; Choi M; Oyekan AO
J Hypertens; 2013 Oct; 31(10):2043-9. PubMed ID: 23811999
[TBL] [Abstract][Full Text] [Related]
31. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression.
Stockmann C; Fandrey J
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):968-79. PubMed ID: 17002676
[TBL] [Abstract][Full Text] [Related]
33. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
34. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
35. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
[TBL] [Abstract][Full Text] [Related]
36. Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Ma M; Hua S; Li G; Wang S; Cheng X; He S; Wu P; Chen X
Oncotarget; 2017 Feb; 8(8):12983-13002. PubMed ID: 28099905
[TBL] [Abstract][Full Text] [Related]
37. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
[TBL] [Abstract][Full Text] [Related]
38. Cellular oxygen sensing need in CNS function: physiological and pathological implications.
Acker T; Acker H
J Exp Biol; 2004 Aug; 207(Pt 18):3171-88. PubMed ID: 15299039
[TBL] [Abstract][Full Text] [Related]
39. The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.
Jaakkola PM; Rantanen K
Biol Chem; 2013 Apr; 394(4):449-57. PubMed ID: 23380539
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
Koivunen P; Kietzmann T
Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
